<?xml version="1.0" encoding="UTF-8"?><!-- generator="podbean/5.5" -->
<rss version="2.0"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:wfw="http://wellformedweb.org/CommentAPI/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
     xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
     xmlns:spotify="http://www.spotify.com/ns/rss"
     xmlns:podcast="https://podcastindex.org/namespace/1.0"
    xmlns:media="http://search.yahoo.com/mrss/">

<channel>
    <title>The Lancet Infectious Diseases in conversation with</title>
    <atom:link href="https://feed.podbean.com/lancetid/feed.xml" rel="self" type="application/rss+xml"/>
    <link>https://lancetid.podbean.com</link>
    <description><![CDATA[<p>The editorial team of <em>The Lancet Infectious Diseases</em>, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy. An audio companion to the journal, this podcast covers a broad range of topics, from mpox diagnostics in Africa, long COVID, adaptive trials in infectious diseases, tuberculosis drug development, and more.</p>]]></description>
    <pubDate>Thu, 07 May 2026 23:30:00 +0000</pubDate>
    <generator>https://podbean.com/?v=5.5</generator>
    <language>en</language>
        <copyright>© 2026 The Lancet Group</copyright>
    <category>Health &amp; Fitness:Medicine</category>
    <ttl>1440</ttl>
    <itunes:type>episodic</itunes:type>
          <itunes:summary></itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
	<itunes:category text="Health &amp; Fitness">
		<itunes:category text="Medicine" />
	</itunes:category>
    <itunes:owner>
        <itunes:name>The Lancet Group</itunes:name>
            </itunes:owner>
    	<itunes:block>No</itunes:block>
	<itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://pbcdn1.podbean.com/imglogo/image-logo/22224340/s6llamiw4gmvno8d4tp32ia2i5ux.jpg" />
    <image>
        <url>https://pbcdn1.podbean.com/imglogo/image-logo/22224340/s6llamiw4gmvno8d4tp32ia2i5ux.jpg</url>
        <title>The Lancet Infectious Diseases in conversation with</title>
        <link>https://lancetid.podbean.com</link>
        <width>144</width>
        <height>144</height>
    </image>
    <item>
        <title>Sara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California</title>
        <itunes:title>Sara Tartof and Matan Yechezkel on durability of doxycycline effectiveness against syphilis, gonorrhoea, and chlamydia after implementation of post-exposure prophylaxis in southern California</itunes:title>
        <link>https://lancetid.podbean.com/e/saratartof-andmatan-yechezkel-ondurabilityof-doxycyclineeffectivenessagainst-syphilis-gonorrhoeaand-chlamydia-afterimplementationof-post-exposure-pro/</link>
                    <comments>https://lancetid.podbean.com/e/saratartof-andmatan-yechezkel-ondurabilityof-doxycyclineeffectivenessagainst-syphilis-gonorrhoeaand-chlamydia-afterimplementationof-post-exposure-pro/#comments</comments>        <pubDate>Thu, 07 May 2026 23:30:00 +0000</pubDate>
        <guid isPermaLink="false">lancetid.podbean.com/893a1249-0e9d-3bd6-87cb-4bb4307f0291</guid>
                                    <description><![CDATA[<p>Sara Tartof and Matan Yechezkel discuss a new article in The Lancet Infectious Diseases about emerging doxycycline resistance against gonorrhoea and its wider implications for the implementation of doxycycline and the prevention of bacterial sexually transmitted infections.</p>
<p>Click here to read the full article:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext?dgcid=podcast_acq-may2026_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Sara Tartof and Matan Yechezkel discuss a new article in The Lancet Infectious Diseases about emerging doxycycline resistance against gonorrhoea and its wider implications for the implementation of doxycycline and the prevention of bacterial sexually transmitted infections.</p>
<p>Click here to read the full article:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext?dgcid=podcast_acq-may2026_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vx8hjet3sqkw9j6n/doxycycline-effectiveness-against-stds.mp3" length="37175887" type="audio/mpeg"/>
        <itunes:summary><![CDATA[Sara Tartof and Matan Yechezkel discuss a new article in The Lancet Infectious Diseases about emerging doxycycline resistance against gonorrhoea and its wider implications for the implementation of doxycycline and the prevention of bacterial sexually transmitted infections.
Click here to read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00123-4/fulltext
The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering.  Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall Podcast editing: Matteo Simonetti Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.  Find the best science for better lives at lancet.comFollow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv]]></itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1548</itunes:duration>
                <itunes:episode>2</itunes:episode>
        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Jenny Clarke and Herve Semukunzi</title>
        <itunes:title>Jenny Clarke and Herve Semukunzi</itunes:title>
        <link>https://lancetid.podbean.com/e/jenny-clarke-and-herve-semukunzi/</link>
                    <comments>https://lancetid.podbean.com/e/jenny-clarke-and-herve-semukunzi/#comments</comments>        <pubDate>Mon, 09 Mar 2026 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-18738920</guid>
                                    <description><![CDATA[<p>Dr Jenny Clarke and Herve Semukunzi discuss a study they and colleagues recently published with us  titled ‘Infection- and vaccine-induced mpox antibodies: validation of a combined mpox IgG ELISA during the clade 1b outbreak in Rwanda’. </p>
<p>They also discuss the reasons for the paucity of validated serological assays for mpox, particularly in outbreak regions where they are most urgently needed. </p>
<p>Click here to read the full article: </p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00006-X/fulltext?dgcid=buzzsprout_podcast_acq-march26_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00006-X/fulltext</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dr Jenny Clarke and Herve Semukunzi discuss a study they and colleagues recently published with us  titled ‘Infection- and vaccine-induced mpox antibodies: validation of a combined mpox IgG ELISA during the clade 1b outbreak in Rwanda’. </p>
<p>They also discuss the reasons for the paucity of validated serological assays for mpox, particularly in outbreak regions where they are most urgently needed. </p>
<p>Click here to read the full article: </p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00006-X/fulltext?dgcid=buzzsprout_podcast_acq-march26_laninf'><b>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(26)00006-X/fulltext</b></a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/3dplyfiv6pepsgl5/1740310_episodes_18738920-jenny-clarke-and-herve-semukunzi.mp3" length="15146077" type="audio/mpeg"/>
        <itunes:summary>Dr Jenny Clarke and Herve Semukunzi discuss a study they and colleagues recently published with us  titled ‘Infection- and vaccine-induced mpox antibodies: validation of a combined mpox IgG ELISA during the clade 1b outbreak in Rwanda’.  They also discuss the reasons for the paucity of validated serological assays for mpox, particularly in outbreak regions where they are most urgently needed.  Click here to read the full article:  https://www.thelancet.com/journals/laninf/...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1259</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Julia Moore Vogel and Danilo Buonsenso on long COVID</title>
        <itunes:title>Julia Moore Vogel and Danilo Buonsenso on long COVID</itunes:title>
        <link>https://lancetid.podbean.com/e/julia-moore-vogel-and-danilo-buonsenso-on-long-covid/</link>
                    <comments>https://lancetid.podbean.com/e/julia-moore-vogel-and-danilo-buonsenso-on-long-covid/#comments</comments>        <pubDate>Fri, 19 Dec 2025 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-18336495</guid>
                                    <description><![CDATA[<p>Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities.</p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities.</p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/gh52hvt4zm1mem34/1740310_episodes_18336495-julia-moore-vogel-and-danilo-buonsenso-on-long-covid.mp3" length="19873448" type="audio/mpeg"/>
        <itunes:summary>Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1653</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>In Conversation with Steven Tong and Joshua Davis on adaptive platform trials</title>
        <itunes:title>In Conversation with Steven Tong and Joshua Davis on adaptive platform trials</itunes:title>
        <link>https://lancetid.podbean.com/e/in-conversation-with-steven-tong-and-joshua-davis-on-adaptive-platform-trials/</link>
                    <comments>https://lancetid.podbean.com/e/in-conversation-with-steven-tong-and-joshua-davis-on-adaptive-platform-trials/#comments</comments>        <pubDate>Thu, 23 Oct 2025 10:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-18028732</guid>
                                    <description><![CDATA[<p>Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.</p>
<p>They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future.</p>
<p><a href='https://www.thelancet.com/journals/laninf/home?dgcid=tlcom_podcast_acq-october%20-2025_lininf'>Click here to read our latest issue</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Professors Steven Tong and Joshua Davis discuss all aspects of <b>adaptive platform trials</b> including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.</p>
<p>They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future.</p>
<p><a href='https://www.thelancet.com/journals/laninf/home?dgcid=tlcom_podcast_acq-october%20-2025_lininf'><b>Click here to read our latest issue</b></a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ey0gvj4tgu8np13k/1740310_episodes_18028732-in-conversation-with-steven-tong-and-joshua-davis-on-adaptive-platform-trials.mp3" length="18613879" type="audio/mpeg"/>
        <itunes:summary>Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them. They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future. Click here to read our latest issue Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://ins...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1548</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases</title>
        <itunes:title>Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases</itunes:title>
        <link>https://lancetid.podbean.com/e/anna-odone-jesus-rodriguez-manzano-and-alex-howard-on-artificial-intelligence-and-infectious-diseases/</link>
                    <comments>https://lancetid.podbean.com/e/anna-odone-jesus-rodriguez-manzano-and-alex-howard-on-artificial-intelligence-and-infectious-diseases/#comments</comments>        <pubDate>Tue, 16 Sep 2025 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-17783244</guid>
                                    <description><![CDATA[<p>Professor Ana Odone, Dr Jesus Rodriguez-Manzano, and Dr Alex Howard discuss their new Series of papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape and in actively shaping artificial intelligence integration into practice.</p>
<p>Read the full Series here:</p>
<p><a href='https://www.thelancet.com/series-do/artificial-intelligence-and-infectious-diseases?dgcid=buzzsprout_icw_podcast_laninfaiandid25_laninf'>https://www.thelancet.com/series-do/artificial-intelligence-and-infectious-diseases?dgcid=buzzsprout_icw_podcast_laninfaiandid25_laninf</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Professor Ana Odone, Dr Jesus Rodriguez-Manzano, and Dr Alex Howard discuss their new Series of papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape and in actively shaping artificial intelligence integration into practice.</p>
<p>Read the full Series here:</p>
<p><a href='https://www.thelancet.com/series-do/artificial-intelligence-and-infectious-diseases?dgcid=buzzsprout_icw_podcast_laninfaiandid25_laninf'>https://www.thelancet.com/series-do/artificial-intelligence-and-infectious-diseases?dgcid=buzzsprout_icw_podcast_laninfaiandid25_laninf</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/ngquec9wrpaw0b5w/1740310_episodes_17783244-anna-odone-jesus-rodriguez-manzano-and-alex-howard-on-artificial-intelligence-and-infectious-diseases.mp3" length="21057990" type="audio/mpeg"/>
        <itunes:summary>Professor Ana Odone, Dr Jesus Rodriguez-Manzano, and Dr Alex Howard discuss their new Series of papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape and in actively shaping artificial intelligence integration into practice. Read the full Series here: https://www.thelancet.com/series-do/artificial-intelligence-and-infectious-diseases?dgcid=buzzsprout_icw_podcast_laninfaiandid25_laninf Continue t...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1752</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
        <podcast:chapters url="https://mcdn.podbean.com/mf/web/iwjpcnjaf72ngidg/1740310_episodes_17783244-anna-odone-jesus-rodriguez-manzano-and-alex-howard-on-artificial-intelligence-and-infectious-diseases_chapters.json" type="application/json" />    </item>
    <item>
        <title>Catherine Liu and Joshua Hill on prevention and management of infections in people who are immunocompromised</title>
        <itunes:title>Catherine Liu and Joshua Hill on prevention and management of infections in people who are immunocompromised</itunes:title>
        <link>https://lancetid.podbean.com/e/catherine-liu-and-joshua-hill-on-prevention-and-management-of-infections-in-people-who-are-immunocompromised/</link>
                    <comments>https://lancetid.podbean.com/e/catherine-liu-and-joshua-hill-on-prevention-and-management-of-infections-in-people-who-are-immunocompromised/#comments</comments>        <pubDate>Mon, 11 Aug 2025 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-17624232</guid>
                                    <description><![CDATA[<p>Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and antimicrobial stewardship.</p>
<p>Read the Series papers:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00345-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00345-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf</a></p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00311-1/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00311-1/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf</a></p>
<p>Read the linked Comment:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00355-X/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00355-X/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and antimicrobial stewardship.</p>
<p>Read the Series papers:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00345-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00345-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf</a></p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00311-1/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00311-1/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf</a></p>
<p>Read the linked Comment:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00355-X/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00355-X/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bvteu36ecj6c0c9q/1740310_episodes_17624232-catherine-liu-and-joshua-hill-on-prevention-and-management-of-infections-in-people-who-are-immunocompromised.mp3" length="13313030" type="audio/mpeg"/>
        <itunes:summary>Drs Catherine Liu and Joshua Hill of the Fred Hutchinson Cancer Center discuss their new Series of papers on the prevention and management of infections in people who are immunocompromised, with a focus on prevention of infections and diagnostic and antimicrobial stewardship. Read the Series papers: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00345-7/fulltext?dgcid=buzzsprout_icw_podcast_August_25_laninf https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1107</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Lilian Tina Minja and Norbert Heinrich on TB drug development</title>
        <itunes:title>Lilian Tina Minja and Norbert Heinrich on TB drug development</itunes:title>
        <link>https://lancetid.podbean.com/e/lilian-tina-minja-and-norbert-heinrich-on-tb-drug-development/</link>
                    <comments>https://lancetid.podbean.com/e/lilian-tina-minja-and-norbert-heinrich-on-tb-drug-development/#comments</comments>        <pubDate>Wed, 09 Jul 2025 08:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-17389838</guid>
                                    <description><![CDATA[<p>Lilian Tina Minja and Norbert Heinrich discuss the SUDUCO and DECODE trials in The Lancet Infectious Diseases on two new promising TB drugs, sutezolid and delpazolid, respectively. They also discuss the wider implications of the findings of these trials for TB drug development and treatment.</p>
<p>Read the trials:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00213-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00213-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf</a></p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00289-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00289-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Lilian Tina Minja and Norbert Heinrich discuss the SUDUCO and DECODE trials in <em>The Lancet Infectious Diseases</em> on two new promising TB drugs, sutezolid and delpazolid, respectively. They also discuss the wider implications of the findings of these trials for TB drug development and treatment.</p>
<p>Read the trials:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00213-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00213-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf</a></p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00289-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00289-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rb7snxvkmez3vikk/1740310_episodes_17389838-lilian-tina-minja-and-norbert-heinrich-on-tb-drug-development.mp3" length="21544476" type="audio/mpeg"/>
        <itunes:summary>Lilian Tina Minja and Norbert Heinrich discuss the SUDUCO and DECODE trials in The Lancet Infectious Diseases on two new promising TB drugs, sutezolid and delpazolid, respectively. They also discuss the wider implications of the findings of these trials for TB drug development and treatment. Read the trials: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00213-0/fulltext?dgcid=buzzsprout_icw_podcast_July_25_laninf https://www.thelancet.com/journals/laninf/article/PIIS1473-...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1793</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile</title>
        <itunes:title>Leonardo Basso and Juan Pablo Torres on the NIRSE-CL study of nirsevimab in Chile</itunes:title>
        <link>https://lancetid.podbean.com/e/leonardo-basso-and-juan-pablo-torres-on-the-nirse-cl-study-of-nirsevimab-in-chile/</link>
                    <comments>https://lancetid.podbean.com/e/leonardo-basso-and-juan-pablo-torres-on-the-nirse-cl-study-of-nirsevimab-in-chile/#comments</comments>        <pubDate>Tue, 10 Jun 2025 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-17072011</guid>
                                    <description><![CDATA[<p>Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond.</p>
<p>Read the full article at: <a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00233-6/fulltext?dgcid=buzzsprout_icw_podcast_10-06-25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00233-6/fulltext?dgcid=buzzsprout_icw_podcast_10-06-25_laninf</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Leonardo Basso and Juan Pablo Torres discuss their study in <em>The Lancet Infectious Diseases</em> on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond.</p>
<p>Read the full article at: <a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00233-6/fulltext?dgcid=buzzsprout_icw_podcast_10-06-25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00233-6/fulltext?dgcid=buzzsprout_icw_podcast_10-06-25_laninf</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/rgftq6hz7nk0x4gd/1740310_episodes_17072011-leonardo-basso-and-juan-pablo-torres-on-the-nirse-cl-study-of-nirsevimab-in-chile.mp3" length="11152052" type="audio/mpeg"/>
        <itunes:summary>Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond. Read the full article at: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)0...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>927</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Jan Felix Drexler and Fernando Bozza on Oropouche virus</title>
        <itunes:title>Jan Felix Drexler and Fernando Bozza on Oropouche virus</itunes:title>
        <link>https://lancetid.podbean.com/e/jan-felix-drexler-and-fernando-bozza-on-oropouche-virus/</link>
                    <comments>https://lancetid.podbean.com/e/jan-felix-drexler-and-fernando-bozza-on-oropouche-virus/#comments</comments>        <pubDate>Mon, 14 Apr 2025 07:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-16910213</guid>
                                    <description><![CDATA[<p>Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control.</p>
<p>Read the full article:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00110-0/fulltext?dgcid=buzzsprout_icw_podcast_14-04-25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00110-0/fulltext?dgcid=buzzsprout_icw_podcast_14-04-25_laninf</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control.</p>
<p>Read the full article:</p>
<p><a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00110-0/fulltext?dgcid=buzzsprout_icw_podcast_14-04-25_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00110-0/fulltext?dgcid=buzzsprout_icw_podcast_14-04-25_laninf</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/yo3atuio8h2vccvu/1740310_episodes_16910213-jan-felix-drexler-and-fernando-bozza-on-oropouche-virus.mp3" length="25428663" type="audio/mpeg"/>
        <itunes:summary>Jan Felix Drexler and Fernando Bozza discuss their recent study published in the journal— “The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America” and its wider implications for Oropouche virus and other arboviruses transmission, expansion, surveillance, and control. Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00110-0/fulltext?dgcid=buzzsprout_icw_podcast_14-04-25_laninf Continue this conversation o...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>2117</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Prasad Kulkarni on dengue monoclonal antibodies</title>
        <itunes:title>Prasad Kulkarni on dengue monoclonal antibodies</itunes:title>
        <link>https://lancetid.podbean.com/e/prasad-kulkarni-on-dengue-monoclonal-antibodies/</link>
                    <comments>https://lancetid.podbean.com/e/prasad-kulkarni-on-dengue-monoclonal-antibodies/#comments</comments>        <pubDate>Fri, 23 Feb 2024 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-14560893</guid>
                                    <description><![CDATA[<p>Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.

Read the full article:
<a href='https://www.thelancet.com/journals/laninf/article/S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf'>https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Prasad Kulkarni discusses a new Phase I trial in <em>The Lancet Infectious Diseases </em>on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/laninf/article/S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf'>https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f4b5nvbqy3snn60w/1740310_episodes_14560893-prasad-kulkarni-on-dengue-monoclonal-antibodies.mp3" length="13618716" type="audio/mpeg"/>
        <itunes:summary>Prasad Kulkarni discusses a new Phase I trial in The Lancet Infectious Diseases on a dengue monoclonal antibody also known as VIS513 in healthy adults. In addition, he highlights the wider implications of this for dengue control and drug development.  Read the full article: https://www.thelancet.com/journals/laninf/article/ S1473-3099(24)00030-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1133</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Oriol Mitjà on treatment of early syphilis in adults</title>
        <itunes:title>Oriol Mitjà on treatment of early syphilis in adults</itunes:title>
        <link>https://lancetid.podbean.com/e/oriol-mitja-on-treatment-of-early-syphilis-in-adults/</link>
                    <comments>https://lancetid.podbean.com/e/oriol-mitja-on-treatment-of-early-syphilis-in-adults/#comments</comments>        <pubDate>Mon, 08 Jan 2024 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-14269631</guid>
                                    <description><![CDATA[<p>Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis.

Read the full article:
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Oriol Mitjà discusses a new trial in <em>The Lancet Infectious Diseases </em>on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/cuszq1g5txcufymp/1740310_episodes_14269631-oriol-mitja-on-treatment-of-early-syphilis-in-adults.mp3" length="11131838" type="audio/mpeg"/>
        <itunes:summary>Oriol Mitjà discusses a new trial in The Lancet Infectious Diseases on the use of oral linezolid compared with benzathine penicillin G for the treatment of early syphilis in adults. He also highlights what the trial means for treatment of syphilis.  Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00683-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>925</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique</title>
        <itunes:title>Sofia Viegas and Stefan Niemann on emerging bedaquiline resistance in Mozambique</itunes:title>
        <link>https://lancetid.podbean.com/e/sofia-viegas-and-stefan-niemann-on-emerging-bedaquiline-resistance-in-mozambique/</link>
                    <comments>https://lancetid.podbean.com/e/sofia-viegas-and-stefan-niemann-on-emerging-bedaquiline-resistance-in-mozambique/#comments</comments>        <pubDate>Fri, 10 Nov 2023 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-13925304</guid>
                                    <description><![CDATA[<p>Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis.

Read the full article:
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Sofia Viegas and Stefan Niemann discuss a new article in <em>The Lancet Infectious Diseases</em> about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf'>https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/qjxgzars05c3ls7n/1740310_episodes_13925304-sofia-viegas-and-stefan-niemann-on-emerging-bedaquiline-resistance-in-mozambique.mp3" length="17736112" type="audio/mpeg"/>
        <itunes:summary>Sofia Viegas and Stefan Niemann discuss a new article in The Lancet Infectious Diseases about emerging bedaquiline resistance in Mozambique and its implications for drug resistant tuberculosis and the fight to end tuberculosis.  Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00498-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_laninf Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thel...</itunes:summary>
        <itunes:author>The Lancet Group</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1475</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections</title>
        <itunes:title>Luciano Moreira and Henrik Salje on Wolbachia control of mosquito-borne infections</itunes:title>
        <link>https://lancetid.podbean.com/e/luciano-moreira-and-henrik-salje-on-wolbachia-control-of-mosquito-borne-infections/</link>
                    <comments>https://lancetid.podbean.com/e/luciano-moreira-and-henrik-salje-on-wolbachia-control-of-mosquito-borne-infections/#comments</comments>        <pubDate>Tue, 27 Sep 2022 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-12129543</guid>
                                    <description><![CDATA[<p>Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.

Read the full article:
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00436-4/fulltext'>Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, Brazil</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Luciano Moreira and Henrik Salje discuss a new article in <em>The Lancet Infectious Diseases</em> describing the use of the <em>Wolbachia</em> bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00436-4/fulltext'>Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, Brazil</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/fmueyk57p0wksdbb/1740310_episodes_12129543-luciano-moreira-and-henrik-salje-on-wolbachia-control-of-mosquito-borne-infections.mp3" length="12282861" type="audio/mpeg"/>
        <itunes:summary>Luciano Moreira and Henrik Salje discuss a new article in The Lancet Infectious Diseases describing the use of the Wolbachia bacteria to control the spread of mosquito-borne dengue and chikungunya in Rio de Janeiro, Brazil.  Read the full article: Estimating the effect of the wMel release programme on the incidence of dengue and chikungunya in Rio de Janeiro, Brazil Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup ...</itunes:summary>
        <itunes:author>The Lancet Infectious Diseases</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1021</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Richard Maude on malaria chemoprophylaxis in Cambodia</title>
        <itunes:title>Richard Maude on malaria chemoprophylaxis in Cambodia</itunes:title>
        <link>https://lancetid.podbean.com/e/richard-maude-on-malaria-chemoprophylaxis-in-cambodia/</link>
                    <comments>https://lancetid.podbean.com/e/richard-maude-on-malaria-chemoprophylaxis-in-cambodia/#comments</comments>        <pubDate>Tue, 27 Sep 2022 09:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-11391888</guid>
                                    <description><![CDATA[<p>Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.

Read the full article:
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00492-3/fulltext'>Antimalarial chemoprophylaxis for forest goers in southeast Asia</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Richard Maude discusses a new article in <em>The Lancet Infectious Diseases</em> that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00492-3/fulltext'>Antimalarial chemoprophylaxis for forest goers in southeast Asia</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/f3gmxrf8g77k8988/1740310_episodes_11391888-richard-maude-on-malaria-chemoprophylaxis-in-cambodia.mp3" length="9198264" type="audio/mpeg"/>
        <itunes:summary>Richard Maude discusses a new article in The Lancet Infectious Diseases that assesses the efficacy of malaria chemoprophylaxis among forest goers in Cambodia.  Read the full article: Antimalarial chemoprophylaxis for forest goers in southeast Asia Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv</itunes:summary>
        <itunes:author>The Lancet Infectious Diseases</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>764</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Ben Cowling on COVID-19 vaccines in Hong Kong</title>
        <itunes:title>Ben Cowling on COVID-19 vaccines in Hong Kong</itunes:title>
        <link>https://lancetid.podbean.com/e/ben-cowling-on-covid-19-vaccines-in-hong-kong/</link>
                    <comments>https://lancetid.podbean.com/e/ben-cowling-on-covid-19-vaccines-in-hong-kong/#comments</comments>        <pubDate>Fri, 15 Jul 2022 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-10960817</guid>
                                    <description><![CDATA[<p>Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.

Read the full article:
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext'>Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Ben Cowling discusses a new article in <em>The Lancet Infectious Diseases</em> describing the protection that vaccines are providing against COVID-19 in Hong Kong.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00345-0/fulltext'>Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/nk15pymivcicyv0x/1740310_episodes_10960817-ben-cowling-on-covid-19-vaccines-in-hong-kong.mp3" length="15128267" type="audio/mpeg"/>
        <itunes:summary>Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.  Read the full article: Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lance...</itunes:summary>
        <itunes:author>The Lancet Infectious Diseases</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1258</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Hugh Adler on monkeypox in the UK</title>
        <itunes:title>Hugh Adler on monkeypox in the UK</itunes:title>
        <link>https://lancetid.podbean.com/e/hugh-adler-on-monkeypox-in-the-uk/</link>
                    <comments>https://lancetid.podbean.com/e/hugh-adler-on-monkeypox-in-the-uk/#comments</comments>        <pubDate>Thu, 26 May 2022 13:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-10686089</guid>
                                    <description><![CDATA[<p>Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.

Read the full article:
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00228-6/fulltext'>Clinical features and management of human monkeypox: a retrospective observational study in the UK</a></p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Hugh Adler discusses a new article in <em>The Lancet Infectious Diseases </em>describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.<br>
<br>
Read the full article:<br>
<a href='https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00228-6/fulltext'>Clinical features and management of human monkeypox: a retrospective observational study in the UK</a></p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/84fyb7y3imuh2ekq/1740310_episodes_10686089-hugh-adler-on-monkeypox-in-the-uk.mp3" length="13207699" type="audio/mpeg"/>
        <itunes:summary>Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.  Read the full article: Clinical features and management of human monkeypox: a retrospective observational study in the UK Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal ...</itunes:summary>
        <itunes:author>The Lancet Infectious Diseases</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1097</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs</title>
        <itunes:title>Beate Kampmann, Karen Keddy, and Peter Ghazal on applying big data to childhood infectious diseases in LMICs</itunes:title>
        <link>https://lancetid.podbean.com/e/beate-kampmann-karen-keddy-and-peter-ghazal-on-applying-big-data-to-childhood-infectious-diseases-in-lmics/</link>
                    <comments>https://lancetid.podbean.com/e/beate-kampmann-karen-keddy-and-peter-ghazal-on-applying-big-data-to-childhood-infectious-diseases-in-lmics/#comments</comments>        <pubDate>Tue, 14 Dec 2021 09:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-9717428</guid>
                                    <description><![CDATA[<p>Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs.

Read the full Series:
<a href='https://www.thelancet.com/series/big-data-childhood-infections-LMICs'>https://www.thelancet.com/series/big-data-childhood-infections-LMICs</a> </p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in <em>The Lancet Infectious Diseases</em> and <em>EBioMedicine</em> addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs.<br>
<br>
Read the full Series:<br>
<a href='https://www.thelancet.com/series/big-data-childhood-infections-LMICs'>https://www.thelancet.com/series/big-data-childhood-infections-LMICs</a> </p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/bn5h6oqhszhzkwnz/1740310_episodes_9717428-beate-kampmann-karen-keddy-and-peter-ghazal-on-applying-big-data-to-childhood-infectious-diseases-in-lmics.mp3" length="16070772" type="audio/mpeg"/>
        <itunes:summary>Prof Beate Kampmann, Dr Karen Keddy, and Prof Peter Ghazal discuss a new cross-journal Series in The Lancet Infectious Diseases and EBioMedicine addressing the potential for and challenge of applying big data to childhood infectious diseases in LMICs.  Read the full Series: https://www.thelancet.com/series/big-data-childhood-infections-LMICs  Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.co...</itunes:summary>
        <itunes:author>The Lancet Infectious Diseases</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1336</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Laura Cooper and Sam Okiror on polio eradication in Africa</title>
        <itunes:title>Laura Cooper and Sam Okiror on polio eradication in Africa</itunes:title>
        <link>https://lancetid.podbean.com/e/laura-cooper-and-sam-okiror-on-polio-eradication-in-africa/</link>
                    <comments>https://lancetid.podbean.com/e/laura-cooper-and-sam-okiror-on-polio-eradication-in-africa/#comments</comments>        <pubDate>Tue, 12 Oct 2021 10:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-9353697</guid>
                                    <description><![CDATA[<p>A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.

Read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltext</p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.<br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltext</p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/aihe1qk1pa6z6j9e/1740310_episodes_9353697-laura-cooper-and-sam-okiror-on-polio-eradication-in-africa.mp3" length="15563477" type="audio/mpeg"/>
        <itunes:summary>A new article highlights how changing immunity profiles motivate the need for better responses to outbreaks of polio in Africa.  Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00453-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv</itunes:summary>
        <itunes:author>The Lancet Infectious Diseases</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1294</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Paul Chapman on a hookworm vaccine</title>
        <itunes:title>Paul Chapman on a hookworm vaccine</itunes:title>
        <link>https://lancetid.podbean.com/e/paul-chapman-on-a-hookworm-vaccine/</link>
                    <comments>https://lancetid.podbean.com/e/paul-chapman-on-a-hookworm-vaccine/#comments</comments>        <pubDate>Thu, 19 Aug 2021 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-9011182</guid>
                                    <description><![CDATA[<p>Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. 

Read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltext

</p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated <em>Necator americanus</em> hookworm larvae. <br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltext<br>
<br>
</p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/vcihisaqsn2gavkn/1740310_episodes_9011182-paul-chapman-on-a-hookworm-vaccine.mp3" length="15118301" type="audio/mpeg"/>
        <itunes:summary>Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae.   Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltext   Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/...</itunes:summary>
        <itunes:author>The Lancet Infectious Diseases</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>1257</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Josep Llibre on preventing SARS-CoV-2 transmission at concerts</title>
        <itunes:title>Josep Llibre on preventing SARS-CoV-2 transmission at concerts</itunes:title>
        <link>https://lancetid.podbean.com/e/josep-llibre-on-preventing-sars-cov-2-transmission-at-concerts/</link>
                    <comments>https://lancetid.podbean.com/e/josep-llibre-on-preventing-sars-cov-2-transmission-at-concerts/#comments</comments>        <pubDate>Thu, 27 May 2021 22:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-8598380</guid>
                                    <description><![CDATA[<p>Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain.

Read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-1/fulltext</p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain.<br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-1/fulltext</p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/pksjpjrl8qugtf9s/1740310_episodes_8598380-josep-llibre-on-preventing-sars-cov-2-transmission-at-concerts.mp3" length="5920676" type="audio/mpeg"/>
        <itunes:summary>Josep Llibre discusses a trial on the impact of same-day testing for SARS-CoV-2 infection before a concert on new COVID-19 cases in Barcelona, Spain.  Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00268-1/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelan...</itunes:summary>
        <itunes:author>The Lancet Infectious Diseases</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>490</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
    <item>
        <title>Yap Boum on COVID-19 testing in low resource settings</title>
        <itunes:title>Yap Boum on COVID-19 testing in low resource settings</itunes:title>
        <link>https://lancetid.podbean.com/e/yap-boum-on-covid-19-testing-in-low-resource-settings/</link>
                    <comments>https://lancetid.podbean.com/e/yap-boum-on-covid-19-testing-in-low-resource-settings/#comments</comments>        <pubDate>Thu, 25 Mar 2021 23:00:00 +0000</pubDate>
        <guid isPermaLink="false">Buzzsprout-8201642</guid>
                                    <description><![CDATA[<p>Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources.

Read the full article:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/fulltext</p>
<p>Continue this conversation on social!
Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p>The Lancet Infectious Diseases in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a>

Follow us today at...
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></description>
                                                            <content:encoded><![CDATA[<p>Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources.<br>
<br>
Read the full article:<br>
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/fulltext</p>
<p>Continue this conversation on social!<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
<p><em>The Lancet Infectious Diseases</em> in conversation with...  is part of the Lancet Group podcast offering. </p>
 <p>Editorial team: editor-in-chief Ursula Hofer, deputy editor Marco De Ambrogi, and senior editors Syeda Saleha Hassan and Phoebe Hall</p>
 <p>Podcast editing: Matteo Simonetti</p>
 <p>Visit <a href='https://www.thelancet.com/multimedia?dgcid=buzzsprout_podcast_tlp_mm'>https://www.thelancet.com/multimedia</a> to learn more about our multimedia offering. </p>
 <p>Find the best science for better lives at <a href='https://www.thelancet.com/journals/laninf/home'>lancet.com</a><br>
<br>
Follow us today at...<br>
<a href='https://thelancet.bsky.social/'>https://thelancet.bsky.social/</a><br>
<a href='https://instagram.com/thelancetgroup'>https://instagram.com/thelancetgroup</a><br>
<a href='https://facebook.com/thelancetmedicaljournal'>https://facebook.com/thelancetmedicaljournal</a><br>
<a href='https://linkedin.com/company/the-lancet'>https://linkedIn.com/company/the-lancet</a><br>
<a href='https://www.youtube.com/thelancettv'>https://youtube.com/thelancettv</a></p>
]]></content:encoded>
                                    
        <enclosure url="https://mcdn.podbean.com/mf/web/7iywfmxpfjs9lje7/1740310_episodes_8201642-yap-boum-on-covid-19-testing-in-low-resource-settings.mp3" length="8206706" type="audio/mpeg"/>
        <itunes:summary>Yap Boum (MSF) discusses his study done in Cameroon, which developed a promising testing strategy for COVID-19 to optimise the available resources.  Read the full article: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00132-8/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelance...</itunes:summary>
        <itunes:author>The Lancet Infectious Diseases</itunes:author>
        <itunes:explicit>false</itunes:explicit>
        <itunes:block>No</itunes:block>
        <itunes:duration>681</itunes:duration>
                        <itunes:episodeType>full</itunes:episodeType>
            </item>
</channel>
</rss>
